Veradigm | Les Charges D'Exploitation



Les Charges D'Exploitation Changement Date
Alcidion AUD 22.7M 3.96M 2025-06
Ambu A/S DKK 1.39B 75M 2025-12
Amplifon EUR 539.04M 16.22M 2025-09
Cardinal Health USD -2.88B 5M 2025-12
Centene USD 50.96B 30.01B 2025-12
Charles River Laboratories USD 3.41B 2.51B 2025-09
Cigna USD 41.8B 23.4B 2025-09
Convatec Group USD 1B 518M 2024-12
CVS Health USD 103.58B 3.66B 2025-12
Diasorin EUR 224.05M 6.89M 2025-09
Elevance Health USD 49.17B 5.21B 2025-12
General Electric Aerospace USD 10.94B 7.87B 2025-12
Gulf Medical Proj AED 170.49M 21.93M 2025-06
Humana USD 33.32B 1.07B 2025-12
IQVIA Holdings USD 1.69B 4.47B 2025-12
Laboratory Of America USD 3.17B 101.7M 2025-09
Maximus USD 1.72B 524.26M 2025-12
McKesson USD 104.5B 2.85B 2025-12
Med Life RON 747.87M 6.92M 2025-09
Molina Healthcare USD 11.53B 191M 2025-12
Omnicell USD 312.8M 13.16M 2025-12
Oriola-kd EUR 456.7M 38.6M 2025-09
Owens Minor USD -429.51M 1.05B 2025-09
Quest Diagnostics USD 2.42B 4.84B 2025-12
Rede D'or Sao Luiz BRL 11.68B 21.3M 2025-09
Siemens Healthineers EUR 4.73B 706M 2025-12
Sonova Holding CHF 1.52B 59.9M 2025-12
Supermax Corporation Bhd MYR 348.72M 89.13M 2025-09
UnitedHealth USD 109.96B 1.11B 2025-12
Veeva Systems USD 570.38M 7.84M 2025-09
Xerox USD 365M 1.18B 2025-09


Veradigm Les Charges D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.